Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 15/20 | 0.47 |
| ▸ | CTSG | P08311 | 1/20 | 0.47 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.46 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.43 |
| ▸ | CMA1 | P23946 | 2/20 | 0.43 |
| ▸ | PREP | P48147 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28626507 | 1.00 | ELANE (0.47) | ELANECTSGTAAR1MALT1CMA1 | |
| SCHEMBL28626509 | 1.00 | ELANE (0.47) | ELANECTSGTAAR1MALT1CMA1 | |
| SCHEMBL20511002 | 0.82 | ELANE (0.42) | ELANE | |
| SCHEMBL20511009 | 0.82 | ELANE (0.42) | ELANE | |
| SCHEMBL20511005 | 0.82 | ELANE (0.42) | ELANE | |
| SCHEMBL23969585 | 0.82 | ELANE (0.51) | ELANECTSGTAAR1MALT1CMA1 | |
| SCHEMBL28866281 | 0.81 | ELANE (0.51) | ELANECTSGTAAR1MALT1CMA1 | |
| SCHEMBL23969580 | 0.81 | ELANE (0.51) | ELANECTSGTAAR1MALT1CMA1 | |
| SCHEMBL28866278 | 0.81 | ELANE (0.51) | ELANECTSGTAAR1MALT1CMA1 | |
| SCHEMBL3935563 | 0.80 | ELANE (0.67) | ELANECTSGCMA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113372368-B | Prodrug of elastase inhibitor and application thereof | 苏州爱科百发生物医药技术有限公司 | 2022-04-12 | — | — | CN | disclosed |
| CN-113372368-A | Prodrug of elastase inhibitor and application thereof | 苏州爱科百发生物医药技术有限公司 | 2021-09-10 | — | — | CN | disclosed |